[
    {
        "text": "what I'm going to do first is briefly",
        "start": 0.0,
        "duration": 5.25
    },
    {
        "text": "summarize some of the work that our",
        "start": 2.689,
        "duration": 4.721
    },
    {
        "text": "group and our collaborators have been",
        "start": 5.25,
        "duration": 5.13
    },
    {
        "text": "carrying on try to figure out the",
        "start": 7.41,
        "duration": 4.62
    },
    {
        "text": "physiological roles of insulin degrading",
        "start": 10.38,
        "duration": 3.99
    },
    {
        "text": "enzyme as well to provide some of the",
        "start": 12.03,
        "duration": 3.919
    },
    {
        "text": "first-ever proof of principle",
        "start": 14.37,
        "duration": 3.84
    },
    {
        "text": "experiments that validated this target",
        "start": 15.949,
        "duration": 6.67
    },
    {
        "text": "for type 2 diabetes so to kick off these",
        "start": 18.21,
        "duration": 6.63
    },
    {
        "text": "panels represent the main strategies",
        "start": 22.619,
        "duration": 6.391
    },
    {
        "text": "that we have nowadays to treat diabetes",
        "start": 24.84,
        "duration": 6.9
    },
    {
        "text": "and they hinge on some aspect of insulin",
        "start": 29.01,
        "duration": 5.7
    },
    {
        "text": "biology to try to lower blood glucose",
        "start": 31.74,
        "duration": 5.52
    },
    {
        "text": "levels which are toxic when elevated and",
        "start": 34.71,
        "duration": 5.88
    },
    {
        "text": "also cause all the undesirable symptoms",
        "start": 37.26,
        "duration": 6.569
    },
    {
        "text": "of diabetes when left unchecked and the",
        "start": 40.59,
        "duration": 5.64
    },
    {
        "text": "oldest method before is the direct",
        "start": 43.829,
        "duration": 6.361
    },
    {
        "text": "injection of insulin supplements by with",
        "start": 46.23,
        "duration": 5.64
    },
    {
        "text": "this insulin analogs I have extended",
        "start": 50.19,
        "duration": 3.36
    },
    {
        "text": "half-lives we can also force the",
        "start": 51.87,
        "duration": 3.36
    },
    {
        "text": "pancreas to produce a little bit more",
        "start": 53.55,
        "duration": 4.23
    },
    {
        "text": "insulin with small molecules and this",
        "start": 55.23,
        "duration": 5.489
    },
    {
        "text": "hormone memetics and we can also",
        "start": 57.78,
        "duration": 5.34
    },
    {
        "text": "sensitize the cells to the action of",
        "start": 60.719,
        "duration": 4.681
    },
    {
        "text": "insulin to some extent however there is",
        "start": 63.12,
        "duration": 4.71
    },
    {
        "text": "a fourth approach that up to now has not",
        "start": 65.4,
        "duration": 4.17
    },
    {
        "text": "been realized in to human therapeutics",
        "start": 67.83,
        "duration": 5.49
    },
    {
        "text": "and we believe that inhibiting the",
        "start": 69.57,
        "duration": 5.46
    },
    {
        "text": "degradation of insulin that has been",
        "start": 73.32,
        "duration": 4.17
    },
    {
        "text": "produced by the pancreas endogenously in",
        "start": 75.03,
        "duration": 4.409
    },
    {
        "text": "response to nutrients it's a very",
        "start": 77.49,
        "duration": 4.199
    },
    {
        "text": "logical and complimentary way to lower",
        "start": 79.439,
        "duration": 5.011
    },
    {
        "text": "blood glucose levels and because this",
        "start": 81.689,
        "duration": 6.031
    },
    {
        "text": "approach is compatible with some of the",
        "start": 84.45,
        "duration": 5.4
    },
    {
        "text": "pill based small molecule treatments",
        "start": 87.72,
        "duration": 4.469
    },
    {
        "text": "that are shown on this slide we may be",
        "start": 89.85,
        "duration": 5.01
    },
    {
        "text": "able to find a unique treatment",
        "start": 92.189,
        "duration": 5.461
    },
    {
        "text": "combination that spares patients of the",
        "start": 94.86,
        "duration": 4.38
    },
    {
        "text": "daily and weekly injections that they",
        "start": 97.65,
        "duration": 3.329
    },
    {
        "text": "need to take for instance implementation",
        "start": 99.24,
        "duration": 3.39
    },
    {
        "text": "so there seems to be a lot of drugs in",
        "start": 100.979,
        "duration": 3.53
    },
    {
        "text": "this field but they're still",
        "start": 102.63,
        "duration": 5.309
    },
    {
        "text": "significantly unmet medical need to",
        "start": 104.509,
        "duration": 6.79
    },
    {
        "text": "properly control blood glucose so",
        "start": 107.939,
        "duration": 8.401
    },
    {
        "text": "missing an image here see okay",
        "start": 111.299,
        "duration": 6.39
    },
    {
        "text": "so here's a nice picture of insulin",
        "start": 116.34,
        "duration": 2.52
    },
    {
        "text": "degrading and some on the on the",
        "start": 117.689,
        "duration": 4.5
    },
    {
        "text": "right-hand side you do the others anyway",
        "start": 118.86,
        "duration": 6.149
    },
    {
        "text": "so insulin is an extremely dynamic",
        "start": 122.189,
        "duration": 6.511
    },
    {
        "text": "hormone it half-life in in vivo is just",
        "start": 125.009,
        "duration": 6.421
    },
    {
        "text": "under five minutes and the main pathway",
        "start": 128.7,
        "duration": 4.89
    },
    {
        "text": "of inactivation is by proteolytically",
        "start": 131.43,
        "duration": 4.199
    },
    {
        "text": "which by these very aptly named enzyme",
        "start": 133.59,
        "duration": 5.85
    },
    {
        "text": "and IDE is a sink dependent metal",
        "start": 135.629,
        "duration": 6.871
    },
    {
        "text": "protease that is ubiquitously expressed",
        "start": 139.44,
        "duration": 7.409
    },
    {
        "text": "and it's actually one of the few Proteus",
        "start": 142.5,
        "duration": 7.86
    },
    {
        "text": "genes that are linked to the disease by",
        "start": 146.849,
        "duration": 5.22
    },
    {
        "text": "genome-wide Association studies in human",
        "start": 150.36,
        "duration": 3.72
    },
    {
        "text": "populations so it is a good candidate",
        "start": 152.069,
        "duration": 5.06
    },
    {
        "text": "for this job of in activating insulin",
        "start": 154.08,
        "duration": 6.239
    },
    {
        "text": "but even well before these modern dick",
        "start": 157.129,
        "duration": 5.89
    },
    {
        "text": "era of genetics we knew about this",
        "start": 160.319,
        "duration": 5.431
    },
    {
        "text": "enzyme because he has been isolated as",
        "start": 163.019,
        "duration": 7.021
    },
    {
        "text": "far back as 1949 by careful",
        "start": 165.75,
        "duration": 6.959
    },
    {
        "text": "fractionation of cow livers and then it",
        "start": 170.04,
        "duration": 4.02
    },
    {
        "text": "was cloned in the 80s and further",
        "start": 172.709,
        "duration": 2.581
    },
    {
        "text": "characterized in the nineties so there",
        "start": 174.06,
        "duration": 3.509
    },
    {
        "text": "was decades of speculation that perhaps",
        "start": 175.29,
        "duration": 5.009
    },
    {
        "text": "blocking this enzyme in an animal may",
        "start": 177.569,
        "duration": 5.121
    },
    {
        "text": "lead to a treatment for type 2 diabetes",
        "start": 180.299,
        "duration": 5.731
    },
    {
        "text": "but up to now it has not been possible",
        "start": 182.69,
        "duration": 6.579
    },
    {
        "text": "to validate this hypotheses because we",
        "start": 186.03,
        "duration": 5.489
    },
    {
        "text": "lack the hitters that were both specific",
        "start": 189.269,
        "duration": 5.881
    },
    {
        "text": "for this enzyme and acting in vivo so we",
        "start": 191.519,
        "duration": 5.61
    },
    {
        "text": "entered this field when we discover the",
        "start": 195.15,
        "duration": 3.63
    },
    {
        "text": "first physiologically active inhibitor",
        "start": 197.129,
        "duration": 5.61
    },
    {
        "text": "of IDE starting from an unbiased DNA",
        "start": 198.78,
        "duration": 6.09
    },
    {
        "text": "encoded library of micro cyclic peptides",
        "start": 202.739,
        "duration": 4.411
    },
    {
        "text": "and in this approach the entire library",
        "start": 204.87,
        "duration": 5.519
    },
    {
        "text": "of DNA encoded compounds is exposed to",
        "start": 207.15,
        "duration": 5.339
    },
    {
        "text": "the target in a one-pot experiment and",
        "start": 210.389,
        "duration": 4.111
    },
    {
        "text": "the target is immobilized on beads using",
        "start": 212.489,
        "duration": 5.551
    },
    {
        "text": "an affinity tag and that generates an",
        "start": 214.5,
        "duration": 5.34
    },
    {
        "text": "enrichment perturbation in the",
        "start": 218.04,
        "duration": 3.539
    },
    {
        "text": "composition of the library that you can",
        "start": 219.84,
        "duration": 3.57
    },
    {
        "text": "deconvolute by high throughput DNA",
        "start": 221.579,
        "duration": 3.84
    },
    {
        "text": "sequencing of all the DNA barcodes and",
        "start": 223.41,
        "duration": 5.43
    },
    {
        "text": "when we decoded the barcodes that were",
        "start": 225.419,
        "duration": 5.371
    },
    {
        "text": "enriched by IDE as you can see on the",
        "start": 228.84,
        "duration": 5.94
    },
    {
        "text": "left we decoded the structures and",
        "start": 230.79,
        "duration": 6.18
    },
    {
        "text": "synthesizing a large scale we found that",
        "start": 234.78,
        "duration": 4.95
    },
    {
        "text": "these were recent only potent inhibitors",
        "start": 236.97,
        "duration": 5.099
    },
    {
        "text": "for the enzyme showing interesting SAR",
        "start": 239.73,
        "duration": 6.06
    },
    {
        "text": "confirming the interaction so next we",
        "start": 242.069,
        "duration": 6.57
    },
    {
        "text": "investigated these micro cycles by",
        "start": 245.79,
        "duration": 4.71
    },
    {
        "text": "replacing each bill in blocking and",
        "start": 248.639,
        "duration": 4.081
    },
    {
        "text": "validating biochemically but to cut a",
        "start": 250.5,
        "duration": 3.75
    },
    {
        "text": "long story short we arrived at this",
        "start": 252.72,
        "duration": 3.66
    },
    {
        "text": "compound that had very good properties",
        "start": 254.25,
        "duration": 4.47
    },
    {
        "text": "as the first physiologically active Pro",
        "start": 256.38,
        "duration": 5.55
    },
    {
        "text": "and we also created this inactive",
        "start": 258.72,
        "duration": 6.03
    },
    {
        "text": "control control compound that is",
        "start": 261.93,
        "duration": 5.49
    },
    {
        "text": "identical in connectivity but has a",
        "start": 264.75,
        "duration": 5.19
    },
    {
        "text": "of Carroll Center switched so that it",
        "start": 267.42,
        "duration": 3.9
    },
    {
        "text": "abrogates money to a target and that",
        "start": 269.94,
        "duration": 2.67
    },
    {
        "text": "will be an injection controlling some",
        "start": 271.32,
        "duration": 4.53
    },
    {
        "text": "experiments one serendipitous",
        "start": 272.61,
        "duration": 5.46
    },
    {
        "text": "observation that was really helpful for",
        "start": 275.85,
        "duration": 4.32
    },
    {
        "text": "the development of this compounds as you",
        "start": 278.07,
        "duration": 4.65
    },
    {
        "text": "can see in this ic50 curves is that this",
        "start": 280.17,
        "duration": 5.04
    },
    {
        "text": "micro-cycles were exquisitely selective",
        "start": 282.72,
        "duration": 6.93
    },
    {
        "text": "for ID well over a thousand fold versus",
        "start": 285.21,
        "duration": 6.12
    },
    {
        "text": "all these other representative",
        "start": 289.65,
        "duration": 3.63
    },
    {
        "text": "metalloprotease from algae families in",
        "start": 291.33,
        "duration": 3.96
    },
    {
        "text": "particularly when you compare to this",
        "start": 293.28,
        "duration": 6.21
    },
    {
        "text": "more traditional inhibitor that it's not",
        "start": 295.29,
        "duration": 6.3
    },
    {
        "text": "very selective because it relies on an",
        "start": 299.49,
        "duration": 4.08
    },
    {
        "text": "interaction with the sink atom in order",
        "start": 301.59,
        "duration": 4.23
    },
    {
        "text": "to inhibit the enzyme and this enzyme is",
        "start": 303.57,
        "duration": 3.81
    },
    {
        "text": "don't have very different catalytic",
        "start": 305.82,
        "duration": 4.89
    },
    {
        "text": "pockets so it's not very like this so",
        "start": 307.38,
        "duration": 5.1
    },
    {
        "text": "I'm gonna skip the pharmacokinetics",
        "start": 310.71,
        "duration": 3.42
    },
    {
        "text": "study but suffice it to say that with",
        "start": 312.48,
        "duration": 3.81
    },
    {
        "text": "one injection exceeds pk we can engage",
        "start": 314.13,
        "duration": 4.59
    },
    {
        "text": "the target for around four hours at a",
        "start": 316.29,
        "duration": 4.98
    },
    {
        "text": "hundredfold or more the necessary",
        "start": 318.72,
        "duration": 4.44
    },
    {
        "text": "concentration for inhibition so during",
        "start": 321.27,
        "duration": 4.62
    },
    {
        "text": "this timeframe what we can do is perform",
        "start": 323.16,
        "duration": 4.83
    },
    {
        "text": "some of the standard experiments in the",
        "start": 325.89,
        "duration": 4.59
    },
    {
        "text": "field such as the glucose tolerance test",
        "start": 327.99,
        "duration": 5.94
    },
    {
        "text": "that is the same assay that is used to",
        "start": 330.48,
        "duration": 6.21
    },
    {
        "text": "diagnose diabetes in the clinic in a",
        "start": 333.93,
        "duration": 4.5
    },
    {
        "text": "typical experiment you see the surge in",
        "start": 336.69,
        "duration": 3.9
    },
    {
        "text": "blood glucose levels that then we then",
        "start": 338.43,
        "duration": 4.8
    },
    {
        "text": "control back down to baseline at a rate",
        "start": 340.59,
        "duration": 4.32
    },
    {
        "text": "that depends on the metabolism and the",
        "start": 343.23,
        "duration": 3.84
    },
    {
        "text": "insulin resistance of the animal so this",
        "start": 344.91,
        "duration": 4.2
    },
    {
        "text": "is the result of the same procedure ran",
        "start": 347.07,
        "duration": 4.8
    },
    {
        "text": "on a diet obese that induce obese Mouse",
        "start": 349.11,
        "duration": 4.74
    },
    {
        "text": "that has been fed a high-fat diet",
        "start": 351.87,
        "duration": 4.71
    },
    {
        "text": "throughout his life in order to elicit",
        "start": 353.85,
        "duration": 4.83
    },
    {
        "text": "insulin resistance which is a model of",
        "start": 356.58,
        "duration": 5.07
    },
    {
        "text": "type 2 diabetes so in the key experiment",
        "start": 358.68,
        "duration": 5.16
    },
    {
        "text": "when these mice were treated with the",
        "start": 361.65,
        "duration": 4.32
    },
    {
        "text": "active compound here in green they",
        "start": 363.84,
        "duration": 4.56
    },
    {
        "text": "displace significantly faster clearance",
        "start": 365.97,
        "duration": 4.41
    },
    {
        "text": "of blood glucose compared to the animals",
        "start": 368.4,
        "duration": 3.66
    },
    {
        "text": "treated with vehicle or they enacted",
        "start": 370.38,
        "duration": 5.43
    },
    {
        "text": "control in red and black and this also",
        "start": 372.06,
        "duration": 5.61
    },
    {
        "text": "worked with the lean mice and the diet",
        "start": 375.81,
        "duration": 3.54
    },
    {
        "text": "in use of these mice and this data",
        "start": 377.67,
        "duration": 3.84
    },
    {
        "text": "represented the first observation and",
        "start": 379.35,
        "duration": 5.07
    },
    {
        "text": "first demonstration that acute",
        "start": 381.51,
        "duration": 4.5
    },
    {
        "text": "inhibition of insulin degrading enzyme",
        "start": 384.42,
        "duration": 3.36
    },
    {
        "text": "leads to an improvement in glucose",
        "start": 386.01,
        "duration": 4.14
    },
    {
        "text": "tolerance by boosting insulin levels and",
        "start": 387.78,
        "duration": 5.46
    },
    {
        "text": "when another set of experiments we",
        "start": 390.15,
        "duration": 4.62
    },
    {
        "text": "showed that the effect of I the",
        "start": 393.24,
        "duration": 3.12
    },
    {
        "text": "innovation is actually quite comparable",
        "start": 394.77,
        "duration": 4.41
    },
    {
        "text": "to the safety approved drug januvia",
        "start": 396.36,
        "duration": 3.8
    },
    {
        "text": "those mentioned",
        "start": 399.18,
        "duration": 5.45
    },
    {
        "text": "or and this one this drug works on a",
        "start": 400.16,
        "duration": 5.67
    },
    {
        "text": "completely different enzyme on a",
        "start": 404.63,
        "duration": 3.9
    },
    {
        "text": "different pathway that increases in",
        "start": 405.83,
        "duration": 4.32
    },
    {
        "text": "secretion so these two strategies can",
        "start": 408.53,
        "duration": 3.57
    },
    {
        "text": "actually be combined to have an additive",
        "start": 410.15,
        "duration": 3.51
    },
    {
        "text": "effect and we think that this is one of",
        "start": 412.1,
        "duration": 3.42
    },
    {
        "text": "the very interesting combinations that",
        "start": 413.66,
        "duration": 4.08
    },
    {
        "text": "may enable us to spare patients of",
        "start": 415.52,
        "duration": 6.27
    },
    {
        "text": "insulin injections before meals so",
        "start": 417.74,
        "duration": 5.79
    },
    {
        "text": "however when we were doing more",
        "start": 421.79,
        "duration": 3.93
    },
    {
        "text": "mechanistic experiments we decided to",
        "start": 423.53,
        "duration": 5.46
    },
    {
        "text": "repeat this experiment but in delivering",
        "start": 425.72,
        "duration": 4.92
    },
    {
        "text": "glucose by injection which basically",
        "start": 428.99,
        "duration": 5.22
    },
    {
        "text": "bypasses a labor a regulatory layer of",
        "start": 430.64,
        "duration": 5.28
    },
    {
        "text": "hormones between the gut and the",
        "start": 434.21,
        "duration": 3.39
    },
    {
        "text": "pancreas and what we saw with this",
        "start": 435.92,
        "duration": 3.51
    },
    {
        "text": "fracking phenotype the only difference",
        "start": 437.6,
        "duration": 3.69
    },
    {
        "text": "between these two experiments is the",
        "start": 439.43,
        "duration": 5.01
    },
    {
        "text": "delivery of glucose and we saw this",
        "start": 441.29,
        "duration": 4.53
    },
    {
        "text": "striking phenotype that suggested that",
        "start": 444.44,
        "duration": 3.15
    },
    {
        "text": "we were missing something in our model",
        "start": 445.82,
        "duration": 3.99
    },
    {
        "text": "and when we measure the hormones at",
        "start": 447.59,
        "duration": 4.47
    },
    {
        "text": "these early and late time points we saw",
        "start": 449.81,
        "duration": 4.92
    },
    {
        "text": "we could assign this phenotype to",
        "start": 452.06,
        "duration": 4.98
    },
    {
        "text": "elevate the levels of glucagon which is",
        "start": 454.73,
        "duration": 4.23
    },
    {
        "text": "the hormone that physiologically that's",
        "start": 457.04,
        "duration": 5.7
    },
    {
        "text": "the opposite action to insulin so this",
        "start": 458.96,
        "duration": 5.67
    },
    {
        "text": "observation then led us to a number of",
        "start": 462.74,
        "duration": 2.7
    },
    {
        "text": "biochemical and physiological",
        "start": 464.63,
        "duration": 3.63
    },
    {
        "text": "experiments to demonstrate that I D",
        "start": 465.44,
        "duration": 5.79
    },
    {
        "text": "really modulates the three pancreatic",
        "start": 468.26,
        "duration": 4.98
    },
    {
        "text": "hormones insulin and glucagon being the",
        "start": 471.23,
        "duration": 4.62
    },
    {
        "text": "main ying and yang of glucose control in",
        "start": 473.24,
        "duration": 4.29
    },
    {
        "text": "the body as well as this secondary",
        "start": 475.85,
        "duration": 4.05
    },
    {
        "text": "hormone amylin that is co-produced and",
        "start": 477.53,
        "duration": 4.47
    },
    {
        "text": "consecrated with insulin by the alpha",
        "start": 479.9,
        "duration": 4.8
    },
    {
        "text": "cells and in the interest of time I will",
        "start": 482.0,
        "duration": 5.669
    },
    {
        "text": "show you the endogenous physiological",
        "start": 484.7,
        "duration": 5.31
    },
    {
        "text": "signaling experiments but in stages at",
        "start": 487.669,
        "duration": 4.291
    },
    {
        "text": "the direct injection of each of the",
        "start": 490.01,
        "duration": 4.62
    },
    {
        "text": "three substrates and the effect that ID",
        "start": 491.96,
        "duration": 4.65
    },
    {
        "text": "inhibition has on the blood glucose",
        "start": 494.63,
        "duration": 5.7
    },
    {
        "text": "effects as well as the plasma levels so",
        "start": 496.61,
        "duration": 6.51
    },
    {
        "text": "to recap up to now using the the first",
        "start": 500.33,
        "duration": 4.77
    },
    {
        "text": "physiologically active compound we could",
        "start": 503.12,
        "duration": 4.47
    },
    {
        "text": "demonstrate that we can improve glucose",
        "start": 505.1,
        "duration": 4.92
    },
    {
        "text": "tolerance by an inhibition",
        "start": 507.59,
        "duration": 6.3
    },
    {
        "text": "however this mostly relies on a moment",
        "start": 510.02,
        "duration": 6.42
    },
    {
        "text": "in which the pancreas is responsible for",
        "start": 513.89,
        "duration": 5.82
    },
    {
        "text": "coordinating a response to an integral",
        "start": 516.44,
        "duration": 6.51
    },
    {
        "text": "nutrient like a meal and at this point",
        "start": 519.71,
        "duration": 5.37
    },
    {
        "text": "there is really high secretion of",
        "start": 522.95,
        "duration": 3.48
    },
    {
        "text": "insulin and suppressed",
        "start": 525.08,
        "duration": 4.62
    },
    {
        "text": "secretion of glucagon but in conditions",
        "start": 526.43,
        "duration": 5.31
    },
    {
        "text": "that do favour some glucose signaling we",
        "start": 529.7,
        "duration": 2.97
    },
    {
        "text": "can see elevated",
        "start": 531.74,
        "duration": 4.02
    },
    {
        "text": "can you Genesis and this is still very",
        "start": 532.67,
        "duration": 4.8
    },
    {
        "text": "promising especially if you consider all",
        "start": 535.76,
        "duration": 3.21
    },
    {
        "text": "the FDA approved drugs that we can",
        "start": 537.47,
        "duration": 3.81
    },
    {
        "text": "combine with these inhibitors but it is",
        "start": 538.97,
        "duration": 3.98
    },
    {
        "text": "still a potential hindrance to the",
        "start": 541.28,
        "duration": 3.84
    },
    {
        "text": "translation of these compounds toward",
        "start": 542.95,
        "duration": 3.64
    },
    {
        "text": "the clinic and the daily routine of",
        "start": 545.12,
        "duration": 5.01
    },
    {
        "text": "patients so we ask this question what if",
        "start": 546.59,
        "duration": 4.92
    },
    {
        "text": "instead of using this blunt-force",
        "start": 550.13,
        "duration": 3.45
    },
    {
        "text": "inhibition approach there was a more of",
        "start": 551.51,
        "duration": 4.98
    },
    {
        "text": "a velvet gravel proach to modulating it",
        "start": 553.58,
        "duration": 4.38
    },
    {
        "text": "on degrading enzyme in a way that it",
        "start": 556.49,
        "duration": 4.95
    },
    {
        "text": "favors the substrate that we want and",
        "start": 557.96,
        "duration": 5.76
    },
    {
        "text": "hopefully this video will illustrate why",
        "start": 561.44,
        "duration": 4.2
    },
    {
        "text": "we thought that we had a reasonable",
        "start": 563.72,
        "duration": 5.16
    },
    {
        "text": "chance of succeeding even though it is a",
        "start": 565.64,
        "duration": 5.85
    },
    {
        "text": "hypothetically impossible feat for most",
        "start": 568.88,
        "duration": 7.08
    },
    {
        "text": "enzymes so here you see 6pk bound to the",
        "start": 571.49,
        "duration": 6.63
    },
    {
        "text": "enzyme and is binding within the cavity",
        "start": 575.96,
        "duration": 6.51
    },
    {
        "text": "in a distal site far away from the",
        "start": 578.12,
        "duration": 5.94
    },
    {
        "text": "catalytic center where the zinc atom is",
        "start": 582.47,
        "duration": 5.13
    },
    {
        "text": "around eliminations away and by sitting",
        "start": 584.06,
        "duration": 5.43
    },
    {
        "text": "in this pocket most of the macrocycle is",
        "start": 587.6,
        "duration": 4.68
    },
    {
        "text": "occupying the cavity and this volume",
        "start": 589.49,
        "duration": 4.92
    },
    {
        "text": "will obstruct the binding of a substrate",
        "start": 592.28,
        "duration": 5.58
    },
    {
        "text": "that will use that wall in order to be",
        "start": 594.41,
        "duration": 7.14
    },
    {
        "text": "recognized as a substrate so we ask the",
        "start": 597.86,
        "duration": 6.18
    },
    {
        "text": "question what if we could modify or find",
        "start": 601.55,
        "duration": 5.82
    },
    {
        "text": "second-generation compounds that might",
        "start": 604.04,
        "duration": 6.45
    },
    {
        "text": "be able to discriminate between insulin",
        "start": 607.37,
        "duration": 4.83
    },
    {
        "text": "and glucagon based on on their",
        "start": 610.49,
        "duration": 3.57
    },
    {
        "text": "differences and the ways that they bind",
        "start": 612.2,
        "duration": 3.72
    },
    {
        "text": "in so negating is that so",
        "start": 614.06,
        "duration": 5.46
    },
    {
        "text": "mmm so instead of so this would be full",
        "start": 615.92,
        "duration": 8.4
    },
    {
        "text": "of dots showing hits but I'll just skip",
        "start": 619.52,
        "duration": 6.81
    },
    {
        "text": "over and I'll say I'll say this instead",
        "start": 624.32,
        "duration": 4.71
    },
    {
        "text": "of trying to modify our first generation",
        "start": 626.33,
        "duration": 5.19
    },
    {
        "text": "inhibitor what we did is to refurbish it",
        "start": 629.03,
        "duration": 5.58
    },
    {
        "text": "into a fluorescent polarization",
        "start": 631.52,
        "duration": 4.71
    },
    {
        "text": "displacement probe shown on the bottom",
        "start": 634.61,
        "duration": 5.82
    },
    {
        "text": "and what this does it reveals a drop in",
        "start": 636.23,
        "duration": 5.91
    },
    {
        "text": "polarization signal whenever he gets",
        "start": 640.43,
        "duration": 4.44
    },
    {
        "text": "displaced out of the ID cavity so the",
        "start": 642.14,
        "duration": 4.29
    },
    {
        "text": "the plan was to screen a hundred",
        "start": 644.87,
        "duration": 3.63
    },
    {
        "text": "thousand compounds from the diversity",
        "start": 646.43,
        "duration": 4.64
    },
    {
        "text": "oriented synthesis library of the broad",
        "start": 648.5,
        "duration": 6.54
    },
    {
        "text": "and we actually stopped around in a",
        "start": 651.07,
        "duration": 6.4
    },
    {
        "text": "quarter of those hits because we found a",
        "start": 655.04,
        "duration": 4.26
    },
    {
        "text": "sub library that contains a hundred hits",
        "start": 657.47,
        "duration": 6.87
    },
    {
        "text": "that were displaces and from those",
        "start": 659.3,
        "duration": 7.5
    },
    {
        "text": "hundred hits I could find",
        "start": 664.34,
        "duration": 5.13
    },
    {
        "text": "full of compounds that show this",
        "start": 666.8,
        "duration": 6.27
    },
    {
        "text": "discrimination property over between the",
        "start": 669.47,
        "duration": 6.09
    },
    {
        "text": "two substrates and these are dual",
        "start": 673.07,
        "duration": 4.62
    },
    {
        "text": "antibody acids for insulin and green and",
        "start": 675.56,
        "duration": 5.19
    },
    {
        "text": "glucagon in red and and this happens",
        "start": 677.69,
        "duration": 4.38
    },
    {
        "text": "over a range of concentration",
        "start": 680.75,
        "duration": 4.11
    },
    {
        "text": "unlike 6pk that shows an identical ec50",
        "start": 682.07,
        "duration": 5.67
    },
    {
        "text": "for both of these substrates as well as",
        "start": 684.86,
        "duration": 5.58
    },
    {
        "text": "than 100% inhibition maximum and I",
        "start": 687.74,
        "duration": 4.44
    },
    {
        "text": "apologize that now on these stretches",
        "start": 690.44,
        "duration": 4.079
    },
    {
        "text": "will have to be reductive or IP purposes",
        "start": 692.18,
        "duration": 4.649
    },
    {
        "text": "but you can see that these compounds are",
        "start": 694.519,
        "duration": 3.961
    },
    {
        "text": "now significantly smaller and drug-like",
        "start": 696.829,
        "duration": 5.0
    },
    {
        "text": "and very promising for pursuing them",
        "start": 698.48,
        "duration": 5.7
    },
    {
        "text": "another cool feature of the way that we",
        "start": 701.829,
        "duration": 4.841
    },
    {
        "text": "perform that screen is that these new",
        "start": 704.18,
        "duration": 4.62
    },
    {
        "text": "inhibitors now inherited the excellent",
        "start": 706.67,
        "duration": 4.47
    },
    {
        "text": "specificity of 6pk because they bind",
        "start": 708.8,
        "duration": 4.08
    },
    {
        "text": "that distal site pocket that really",
        "start": 711.14,
        "duration": 3.509
    },
    {
        "text": "doesn't exist in any other metal",
        "start": 712.88,
        "duration": 5.49
    },
    {
        "text": "protease it in collaboration with the",
        "start": 714.649,
        "duration": 5.281
    },
    {
        "text": "silica lab we recently obtained a",
        "start": 718.37,
        "duration": 3.659
    },
    {
        "text": "crystal structure of one of these",
        "start": 719.93,
        "duration": 5.19
    },
    {
        "text": "analogs and we validated with mutations",
        "start": 722.029,
        "duration": 5.611
    },
    {
        "text": "in those sites shown there and we can",
        "start": 725.12,
        "duration": 5.12
    },
    {
        "text": "now show you how they we think they work",
        "start": 727.64,
        "duration": 6.96
    },
    {
        "text": "if we superimpose the IDE insulin coke",
        "start": 730.24,
        "duration": 6.099
    },
    {
        "text": "crystal structure there is a major",
        "start": 734.6,
        "duration": 3.69
    },
    {
        "text": "steric clash with part of the molecule",
        "start": 736.339,
        "duration": 3.961
    },
    {
        "text": "sticking out into the ID cavity as shown",
        "start": 738.29,
        "duration": 4.95
    },
    {
        "text": "there but glucagon because it is smaller",
        "start": 740.3,
        "duration": 5.94
    },
    {
        "text": "and more flexible it can still use the",
        "start": 743.24,
        "duration": 6.719
    },
    {
        "text": "same wall of the enzyme to interact with",
        "start": 746.24,
        "duration": 6.87
    },
    {
        "text": "Eddy on to regions but it can engage now",
        "start": 749.959,
        "duration": 5.851
    },
    {
        "text": "the catalytic site in a biochemically",
        "start": 753.11,
        "duration": 5.25
    },
    {
        "text": "productive way so depending on the assay",
        "start": 755.81,
        "duration": 4.11
    },
    {
        "text": "and the compound that we are using we",
        "start": 758.36,
        "duration": 5.43
    },
    {
        "text": "see between 60 and 80% of the native",
        "start": 759.92,
        "duration": 8.729
    },
    {
        "text": "activity of the enzyme and just to wrap",
        "start": 763.79,
        "duration": 7.53
    },
    {
        "text": "up one one huge drawback of rescreening",
        "start": 768.649,
        "duration": 4.741
    },
    {
        "text": "is now you have to reapply your compound",
        "start": 771.32,
        "duration": 4.59
    },
    {
        "text": "again and this compounds were around",
        "start": 773.39,
        "duration": 4.23
    },
    {
        "text": "five fold less potent that the first",
        "start": 775.91,
        "duration": 3.63
    },
    {
        "text": "generation inhibitor but we hit some",
        "start": 777.62,
        "duration": 3.329
    },
    {
        "text": "inspiration where we realized that this",
        "start": 779.54,
        "duration": 3.06
    },
    {
        "text": "compounds might be paying an entropic",
        "start": 780.949,
        "duration": 3.991
    },
    {
        "text": "penalty by binding the target having to",
        "start": 782.6,
        "duration": 4.08
    },
    {
        "text": "flip these rings out of the plane so",
        "start": 784.94,
        "duration": 3.63
    },
    {
        "text": "when we lock them in this conformation",
        "start": 786.68,
        "duration": 3.81
    },
    {
        "text": "we got what's called a magic metal",
        "start": 788.57,
        "duration": 4.53
    },
    {
        "text": "effect that improved affinity by 120",
        "start": 790.49,
        "duration": 4.32
    },
    {
        "text": "fold and now you can see that we have",
        "start": 793.1,
        "duration": 3.69
    },
    {
        "text": "these very nice molecules with high",
        "start": 794.81,
        "duration": 4.11
    },
    {
        "text": "potency and they discriminate between",
        "start": 796.79,
        "duration": 3.46
    },
    {
        "text": "insulin glucagon",
        "start": 798.92,
        "duration": 4.51
    },
    {
        "text": "in over three orders of magnitude so",
        "start": 800.25,
        "duration": 5.07
    },
    {
        "text": "what we can do now with this new",
        "start": 803.43,
        "duration": 3.69
    },
    {
        "text": "generation of inhibitors is really block",
        "start": 805.32,
        "duration": 4.35
    },
    {
        "text": "inhibition of insulin degradation over",
        "start": 807.12,
        "duration": 4.68
    },
    {
        "text": "long periods of time allowing glucagon",
        "start": 809.67,
        "duration": 4.53
    },
    {
        "text": "to get degraded and we can see also in",
        "start": 811.8,
        "duration": 4.71
    },
    {
        "text": "the mass spec going away and the main",
        "start": 814.2,
        "duration": 4.65
    },
    {
        "text": "cleavage side is still the same one as",
        "start": 816.51,
        "duration": 5.16
    },
    {
        "text": "the native enzyme so that is perfect for",
        "start": 818.85,
        "duration": 6.9
    },
    {
        "text": "going forward so of hope I've convinced",
        "start": 821.67,
        "duration": 6.36
    },
    {
        "text": "you that IDE is a compelling target for",
        "start": 825.75,
        "duration": 4.5
    },
    {
        "text": "the treatment of type 2 diabetes and",
        "start": 828.03,
        "duration": 4.59
    },
    {
        "text": "that because of its Imperial functions",
        "start": 830.25,
        "duration": 3.99
    },
    {
        "text": "we have to be a little bit smarter about",
        "start": 832.62,
        "duration": 3.53
    },
    {
        "text": "how we go about inhibiting this enzyme",
        "start": 834.24,
        "duration": 4.68
    },
    {
        "text": "but now that we've discovered this such",
        "start": 836.15,
        "duration": 4.48
    },
    {
        "text": "as selecting inhibitors that bind the",
        "start": 838.92,
        "duration": 5.13
    },
    {
        "text": "6pk side we can now selectively disrupt",
        "start": 840.63,
        "duration": 5.61
    },
    {
        "text": "the insulin interaction allowing the",
        "start": 844.05,
        "duration": 5.31
    },
    {
        "text": "glucagon interaction to continue and I",
        "start": 846.24,
        "duration": 5.58
    },
    {
        "text": "just a quick shout-out to my mentors and",
        "start": 849.36,
        "duration": 4.71
    },
    {
        "text": "the some of the collaborators and",
        "start": 851.82,
        "duration": 4.98
    },
    {
        "text": "colleagues that have helped with the",
        "start": 854.07,
        "duration": 5.28
    },
    {
        "text": "story with the validation story with 6pk",
        "start": 856.8,
        "duration": 4.53
    },
    {
        "text": "as well as the Broad Institute",
        "start": 859.35,
        "duration": 3.84
    },
    {
        "text": "collaborators that helped us put in",
        "start": 861.33,
        "duration": 5.07
    },
    {
        "text": "place the screening assay that turned",
        "start": 863.19,
        "duration": 4.74
    },
    {
        "text": "out to find to identify these",
        "start": 866.4,
        "duration": 4.26
    },
    {
        "text": "second-generation compounds and I should",
        "start": 867.93,
        "duration": 4.74
    },
    {
        "text": "say that looking forward what we hope to",
        "start": 870.66,
        "duration": 3.75
    },
    {
        "text": "do is translate some of these findings",
        "start": 872.67,
        "duration": 4.59
    },
    {
        "text": "into Idol by other biomedical targets of",
        "start": 874.41,
        "duration": 5.31
    },
    {
        "text": "interest that have this poly specificity",
        "start": 877.26,
        "duration": 4.17
    },
    {
        "text": "problem for which we are currently",
        "start": 879.72,
        "duration": 3.99
    },
    {
        "text": "they're out of the scope of current",
        "start": 881.43,
        "duration": 3.87
    },
    {
        "text": "innovation approaches or for which we",
        "start": 883.71,
        "duration": 3.48
    },
    {
        "text": "are asking patients to put up with some",
        "start": 885.3,
        "duration": 4.17
    },
    {
        "text": "sort of undesirable side effects from",
        "start": 887.19,
        "duration": 4.88
    },
    {
        "text": "their medicines",
        "start": 889.47,
        "duration": 2.6
    },
    {
        "text": "you",
        "start": 896.6,
        "duration": 2.06
    }
]